new report out on CKK by Coretrack makes interesting reading in terms of the calculated ROIs on the GT3000. All good.http://www.coretrack.com.au/images/stories/CKK060411_Patersons_research_note.pdf
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution